Related references
Note: Only part of the references are listed.Proteasome inhibitors in multiple myeloma: 10 years later
Philippe Moreau et al.
BLOOD (2012)
Combined targeting of MEK/MAPK and PI3K/Akt signalling in multiple myeloma
Torsten Steinbrunn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Finding the weakest link - exploring integrin-mediated mechanical molecular pathways
Pere Roca-Cusachs et al.
JOURNAL OF CELL SCIENCE (2012)
Molecular pathogenesis of multiple myeloma and its premalignant precursor
W. Michael Kuehl et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
Paul J. Davis et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
Christina M. Annunziata et al.
BLOOD (2011)
Thyroid Hormone Is a MAPK-Dependent Growth Factor for Human Myeloma Cells Acting via αvβ3 Integrin
Keren Cohen et al.
MOLECULAR CANCER RESEARCH (2011)
Molecular Aspects of Thyroid Hormone Actions
Sheue-Yann Cheng et al.
ENDOCRINE REVIEWS (2010)
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V. Ramakrishnan et al.
ONCOGENE (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Hung-Yun Lin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
The Thyroid Hormone Receptor (TR) β-Selective Agonist GC-1 Inhibits Proliferation But Induces Differentiation and TR β mRNA Expression in Mouse and Rat Osteoblast-Like Cells
Eduardo H. Beber et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
Marco Tucci et al.
CANCER RESEARCH (2009)
The pro-apoptotic action of stilbene-induced COX-2 in cancer cells Convergence with the anti-apoptotic effect of thyroid hormone
Hung-Yun Lin et al.
CELL CYCLE (2009)
Linking integrin conformation to function
Janet A. Askari et al.
JOURNAL OF CELL SCIENCE (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
Abdelhadi Rebbaa et al.
ANGIOGENESIS (2008)
Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin αVβ3
A. Scarlett et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Molecular modeling of the thyroid hormone interactions with αvβ3 integrin
Vivian Cody et al.
STEROIDS (2007)
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Kathy Mulgrew et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis
JJ Bergh et al.
ENDOCRINOLOGY (2005)
αvβ3 Integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells
H Sekimoto et al.
MOLECULAR ENDOCRINOLOGY (2005)
Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor
HY Tang et al.
ENDOCRINOLOGY (2004)
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy?
A Teti et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and post-transcriptional mechanisms
CH Gouveia et al.
JOURNAL OF ENDOCRINOLOGY (2001)
αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells
A Vacca et al.
EXPERIMENTAL HEMATOLOGY (2001)
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to β1 integrin-dependent cell spreading
K Iba et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
